Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This was 3 months ago
LocationEvent Lounge Brussels
Join EIT Manufacturing for European Manufacturing Conference in Brussels on 24 and 25 September 2024 alongside key manufacturing players to address the pressing challenges faced by the European industry and society today and tomorrow.
Over 350 participants are expected at Event Lounge to engage with policymakers, industry representatives, as well as academia, RTOs, start-ups, scale-ups, and innovators at the European Manufacturing Conference this year. European Manufacturing Conference is co-organised by EFFRA, EIT Manufacturing, and ManuFuture.
Networking: Meet and connect with key players and stakeholders in the industry.
Expo: Learn more about the latest initiatives and programmes these three manufacturing players are involved in.
Insights: Gain valuable insights into innovative manufacturing technologies and trends through panel sessions, fireside chats, and keynote speeches.
Throughout the conference, the programme will tackle several topics, aiming to meet the needs and interests of the manufacturing ecosystem:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI, data & cloud Deployment: Best use of technologies
Security AI, data & cloud Cybersecurity Defence Space
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.